IP Library › Assignment 057246/0693
Patent Assignment
Reel/Frame 057246/0693

Change of Name

Recorded: 2021-08-19 Pages: 4
Assignor
NANTKWEST, INC.
Executed: 2021-03-09
Assignee
IMMUNITYBIO, INC.
9920 JEFFERSON BLVD., CULVER CITY, CALIFORNIA, 90232
Covered Properties (4)
Modified Nk-92 Cells for Treating Cancer
Application: 15/531,109 →
Publication: US 2018/0163176
Modified Nk-92 Cells for Treating Cancer
Application: 16/940,018 →
Publication: US 2021/0054337
Modified Nk-92 Cells and Antibodies for Treating Cancer
Application: 62/173,701 →
Modified Nk-92 Cells for Treating Cancer
Application: 62/337,044 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 17, 2016
From: LEE, TIEN
To: NANTKWEST, INC.
Reel/Frame 038945/0861 →
Assignment of Assignor's Interest Jun 17, 2016
From: LEE, TIEN
To: NANTKWEST, INC.
Reel/Frame 038946/0030 →
Security Interest Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →